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Abstract
Airway smooth muscle (ASM) cells have been shown to play an important role 
in bronchial asthma. As the research progresses, the mechanism becomes more and 
more complex. This chapter reviews the role of ASM in asthma pathological mecha-
nisms including inflammatory reaction, extracellular matrix proteins, cell contrac-
tion, cell structure, neuromodulation, airway remodeling, apoptosis, autophagy, 
miRNA, mitochondria, etc. In brief, ASM is similar to a “processing station.” It is 
not only affected by various signals in the body to produce biological effects and 
secrete various signals to act on downstream target cells but also feeds back to the 
upstream pathways or receives feedback from downstream pathways to form a 
complex network. The results summarized in this chapter are expected to provide 
new targets for the clinical treatment of asthma.
Keywords: airway smooth muscle cells, asthma, inflammation, airway 
hyperreactivity, airway remodeling
1. Introduction
Bronchial asthma is a chronic airway inflammatory disease involving a variety 
of airway inflammatory cells, airway structural cells, and cellular components of 
which airway smooth muscle (ASM) cells have received the most intensive inves-
tigation. ASM has been shown to play an important role in the structure, function, 
and contraction of the airways. Evidence suggests that some ASM signaling mecha-
nisms can help regulate the release of pro-inflammatory and anti-inflammatory 
mediators, which are factors that regulate immunity; different types of airway cells 
(such as epithelial cells, fibroblasts, and nerve cells); intracellular Ca2+ concentra-
tion-mediated airway contraction and relaxation; cell proliferation and apoptosis, 
autophagy, production, and regulation of the extracellular matrix (ECM); and 
neuromodulation. These mechanisms cause structural changes in the narrowing 
and dilatation of the airway, resulting in airway hyperreactivity (AHR) and airway 
stenosis, hence affecting airway compliance.
2.  ASM participates in asthma by releasing pro-inflammatory or 
anti-inflammatory factors and immune regulators
ASM can produce a variety of pro-inflammatory and anti-inflammatory fac-
tors triggered by inflammation, injuries, and microbial products [1], including 
interleukin-1β (IL-1β), IL-5, IL-6, IL-8, IL-17, platelet-derived growth factor 
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(PDGF), transforming growth factor-β (TGF-β), etc., which constitute a complex 
network that participates in airway inflammation. For example, IL-6 induces ASM 
cell proliferation and further modulates immune cell function [2], and TNF-α 
exerts its mediating effects by enhancing interferon (IFNβ) secretion [3]. Recent 
studies have confirmed that ASM can produce and release thymic stromal lym-
phopoietin (TSLP) and can also act as a target of TSLP to participate in the recruit-
ment of dendritic cells to regulate airway immune responses [4, 5]. ASM cells also 
produce chemokines such as RANTES and eotaxin [6]. The specific mechanism 
may be mediated by mitogen-activated protein kinase (MAPK), janus kinase/
signal transducer and activator of transcription protein signaling pathway (JAK/
Stat), and c-jun N-terminal kinase (JNK) [7, 8]. There is also evidence that ASM 
can also secrete growth factors such as vascular endothelial growth factor (VEGF) 
and brain-derived neurotrophic factor (BNDF), and these growth factors may be 
involved in ASM proliferation and contraction through autocrine effects [9].
3. ASM acts on asthma by secreting extracellular matrix (ECM)
The action of ASM ECM proteins on airway remodeling by autocrine or para-
crine effects is a current research focus in asthma. ASM can produce a series of ECM 
proteins [10]. In the airway, ECM proteins surround cells in the form of reticular 
collagen or noncollagen, and their density and structure affect cellular character-
istics such as proliferation, migration, differentiation, and survival. The related 
components include collagen, fibronectin, the matrix metalloprotein (MMP) family 
(MMP-2, MMP-3, MMP-9, MMP-13, etc.), and metalloprotein antagonists (TIMP-1 
and TIMP-2) (Figure 1) [1, 11, 12]. Meanwhile, ECM protein signaling groups can 
in turn regulate other cells such as epithelial cells and ASMs. The ECM can control 
its own conformation, release growth factors, and MMPs and regulate the activity 
of local growth factors (such as neurotrophin and VEGF) and cytokines by cleavage 
Figure 1. 
MMP and TIMP mRNA expression by qRT-PCR five primary ASM cell cultures and expressed relative to 
GAPDH. It was originally published on “Matrix metalloproteinase expression and activity in human airway 
smooth muscle cells” of the British Journal of Pharmacology by Shona R. Elshaw et al.
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and inactivation [13], thereby forming a complex signaling network to regulate 
airway remodeling. For example, IL-1β can interact with tumor necrosis factor-α 
(TNF-α), thus increasing MMP-12 [14] and MMP-9 [15], promoting cell migration 
and remodeling, and further regulating growth factor activity.
In terms of the regulatory mechanisms of the ECM, Rho kinase inhibitors 
can prevent ECM-induced airway remodeling [16]. The Wnt/β-catenin pathway 
can regulate TGF-β regulation of ASM-derived ECM [1, 17]. In contrast, decorin 
(an ECM proteoglycan) binds to TGF-β and reduces ECM production [18]. Even 
infections can regulate ECM products via ASM, and rhinovirus-induced infections 
increase fibronectin and basement membrane glycans, especially in the ASM of 
asthma patients [19]. Thus, altering the production of ECM, thereby modulating 
the inflammatory mediators or growth factors produced by the ASM or other cells, 
may result in cross reaction of airway structures and functions.
4. ASM is involved in asthma through other mechanisms
In addition to inflammatory mediators and growth factors, many emerging 
mechanisms have been reported to be involved in ASM and airway remodeling. For 
example, vitamin D has been shown to inhibit remodeling in vitro and in vivo [20]. 
However, its mechanism involving airway ASM cells is still under investigation [21]. 
Another emerging mechanism is thyroxine, which has been reported to enhance ASM 
proliferation [22], while low thyroxine levels cause airway developmental malforma-
tions [23]. Some reports also suggest that insulin appears to enhance ASM proliferation 
and ECM formation [24]. In addition, sphingolipids participate in airway inflamma-
tion, AHR, and remodeling. In particular, sphingosine-1-phosphate can promote ASM 
contractility and regulate inflammation and airway remodeling [25, 26].
5. Roles of ASM, [Ca2+]i, and contraction mechanisms in asthma
The cytosolic Ca2+ concentration ([Ca2+]i) is a well-established pathway for 
the regulation of ASM contraction. The [Ca2+]i can affect voltage-gated channels, 
receptor-regulated channels, and calcium pool-regulated channels. These channels 
are subjected to regulation by pathways such as phospholipase C (PLC), inositol 
triphosphate (IP3), ryanodine receptor (RyR), etc. (Figure 2). Meanwhile, sarco/
endoplasmic reticulum Ca2+ ATPase (SERCA), bidirectional Na+-Ca2+ exchangers 
(NCX), and mitochondrial buffers can limit [Ca2+]i and regulate calcium storage 
by inhibiting the activation of [Ca2+]i. In addition to [Ca
2+]i, Ca
2+-calmodulin-
dependent myosin light chain (MLC) kinase and MLC act in tandem to regulate 
ASM contractility by excitatory myosin interaction. Studies have shown that the 
Rho-associated coiled-coil containing kinases (ROCK) pathway inhibits the con-
traction of Ca2+-sensitive cells by inhibiting the sensitivity of MLC kinase [27]. IP3 
can activate Ca2+ influx [28] in ASM and regulate local Ca2+ release [29].
5.1 GPCR mechanism and asthma
G-protein-coupled receptors (GPCRs) are a superfamily of cell membrane 
proteins that transduce extracellular signals, causing intracellular cascades and 
leading to different cellular functions. This mechanism is used to treat diseases 
such as asthma and chronic obstructive pulmonary disease (COPD). In ASM, 
most of the existing research focuses on the expression and function of different 
GPCRs (Gq, Gi, and Gs) in ASM contraction/relaxation. For instance, traditional 
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bronchoconstrictor agonists such as acetylcholine (ACh), histamine, and endo-
thelin act through the Gq-coupled pathway, activating the PLC-IP3 pathway and 
thereby increasing Ca2+. However, bronchiectasis caused by the Gs-coupled pathway 
(increasing cAMP) is the major mechanism of action of the β2-adrenergic receptor 
[30]. Moreover, GPCRs alone or in combination with other pathways, such as recep-
tor tyrosine kinases acting through cell proliferation/growth, secretion of growth 
factors, and inflammatory mediators, promote the “synthesis function” of ASM, 
and its remodeling of airways is gaining increasing attention [31].
The current common GPCRs include gamma-aminobutyric acid (GABA), 
calcium-sensing receptor (CaSR), thromboxane (TXA2), bitter taste receptor (BTR), 
and prostaglandin E2 (PGE2). The present research status is summarized as follows.
GABA is a major inhibitory neurotransmitter in the mammalian central nervous 
system and activates both the ligand-gated ionotropic GABAA receptor and the 
G-protein-coupled metabotropic GABAB receptor. Functional GABAB receptors 
are present in ASM [32, 33] and airway epithelium [34]. GABAB produces airway 
contraction through Gi, and the GABAA receptor on ASM appears to be a potent 
bronchodilator [35]. Since the human ASM GABAA receptor only expresses the 
α4 and α5 subunits, recent studies have shown that selective targeting of the ASM 
GABAA receptor can improve the efficacy of anti-asthmatic drugs and minimize 
side effects [36]. The reported data suggest that the heterogeneity of selective 
targeting of ASM GABAA receptor features is a novel approach to bronchiectasis.
CaSR, a GPCR, is often expressed in non-Ca2+-regulated tissues such as blood 
vessels and breasts and can regulate the extracellular Ca2+ concentration ([Ca2+]e), 
gene expression, ion channels, and ECM through the parathyroid glands, kidneys, and 
bones. Abnormal expression of CaSR is usually associated with inflammation, vascular 
Figure 2. 
Signaling pathways of Ca2+ concentration in ASM involving IP3R and RyR and the potential targets of 
mabuterol hydrochloride (Mab) that intervene in the increased level of intracellular Ca2+ induced with Ach. 
Binding with a G-protein-coupled receptor, Ach activates PLC to generate IP3, which encourages the clusters 
of IP3R on SR to release Ca2+. RyR may also be activated or potentiated by cADP ribose (cADPR). It may 
be sequestered by the superficial sarcoplasmic reticulum (SR) through sarcoendoplasmic Ca2+ ATPase 2a 
(SERCA2a), although much of the calcium is released from stores and enters the cytoplasm. The increased level of 
intracellular Ca2+ leads to the contraction, proliferation, and migration of the ASM. It was originally published 
on “Matrix metalloproteinase expression and activity in human airway smooth muscle cells” of the British 
Journal of Pharmacology by Shona R. Elshaw et al. It was originally published on “Suppression of the increasing 
level of acetylcholine-stimulated intracellular Ca2+ in guinea pig airway smooth muscle cells by mabuterol” of 
Biomedical Reports by Xirui Song et al.
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calcification, and tumors. Although CaSR is important in the development of the lungs, 
studies on the expression or function of CaSR in the airways are still rare. CaSR has been 
reported to be expressed in the developing airway epithelium [37] and regulates the mor-
phology of the lung bronchus through [Ca2+]e levels, thereby affecting tracheal remodel-
ing [38]. In adults, CaSR is present in the human respiratory tract, especially in ASM, and 
CaSR expression is increased in ASM of asthmatic subjects [39], which may become a 
new target for future asthma treatment. Depending on the cell type, the expression and 
function of CaSR are regulated by signaling pathways such as ROCK, extracellular signal-
regulated kinase (ERKs), and protein kinase C (PKC) [40]. Therefore, this receptor can 
be considered a multimode sensor and effector for the integration of composite signals 
and has an important impact on airway structure and function.
TXA2 is a potent endogenous bronchoconstrictor that is observed to have 
increased levels in asthmatic airways [41]. TXA2 induces and enhances the con-
traction of allergic bronchi primarily through interaction with the thromboxane 
prostaglandin (TP) receptor coupled to Gq and the PLC/IP3/Ca
2+ pathway. Studies 
have shown that the TXA2 effector mechanism is complex and involves indirect 
effects of neuronal stimulation leading to ACh release and mechanical stimula-
tion [42].
The BTR is a recently discovered bronchodilator. It was originally thought to act 
through the taste 2 receptors (TAS2R) family of GPCRs to increase [Ca2+]i and induce 
bronchiectasis [43]. TAS2Rs exhibit low specificity and affinity for a wide range of 
bitter compounds, and the corresponding result is a diversity of signal combinations. 
Factors affecting TAS2Rs include agonist concentration and receptor desensitization 
[44]. BTR can induce membrane hyperpolarization [45] via the blocker-sensitive 
Ca2+-activated K-channels [43, 46] and nonselective cation channels and interact with 
specific bronchoconstrictors [46]. Moreover, studies have suggested that BTRs can 
activate different Ca2+ signaling pathways under specific conditions. For example, 
TAS2R stimulation activates Gβγ under baseline conditions to increase [Ca2+]i [47]. 
Other studies have also shown that the bronchodilating effect of BTR may also depend 
on interactions with β2-adrenergic receptor expression and signaling [48]. When 
TAS2R is activated, relaxation can be induced even under adrenergic receptor desen-
sitization [48], which may be an alternative treatment method for asthma patients 
with bronchiectasis who are desensitized to β-agonists. Through extensive research, 
BTR has also been shown to affect genetic variations that result in sinusitis and asthma 
[49]; the mechanism by which BTR relaxes the airway has not yet been elucidated.
PGE2 and its epoprostenol (EP) receptor subtype are produced by airway 
epithelium and ASM and have complex effects on bronchoconstriction and expan-
sion. Previous studies have shown that endogenous PGE2 has a bronchial protective 
effect in asthma. The PGE2 signal acts through four different GPCRs (EP1–EP4). 
Since different pathways have different G-protein coupling and downstream 
signals, and some downstream pathways can counteract each other [50], the mecha-
nism of action is complicated. Studies have shown that EP1 increases Ca2+ and EP3 
reduces cAMP synthesis, leading to ASM contraction, while EP2 and EP4 induce 
bronchodilation by increasing cAMP. In addition, EP3 can also cause an opposite 
reaction by promoting ASM migration [51].
In addition to the above GPCR-related mechanisms, many studies have been 
performed on Wnt signaling in the airways in recent years. Wnt proteins act through 
coreceptors such as lipoprotein receptor-associated protein (LRP)-5/LRP-6, recep-
tor-like tyrosine kinase (Ryk), and receptor tyrosine kinase-like orphan receptor 2 
(Ror2) to promote binding to the extracellular domain of the frizzled (Frz) family 
of GPCRs. The Wnt signaling pathways include the classical β-catenin-dependent 
and β-catenin-independent pathways and the noncanonical Wnt/Ca2+ pathway. 
In ASM, Wnt signaling is thought to be closely related to airway remodeling [52]. 
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In fibroblasts, Wnt5B can increase the secretion of IL-6 and chemokine ligand 8 
(CXCL-8) and indirectly affect airway remodeling (69). In epithelial cells, Wnt 
signaling in inflammation produces ECM and indirectly induces remodeling [53].
5.2 Non-GPCR mechanisms and asthma
Regarding airway contraction controlled by non-GPCR mechanisms, the mecha-
nism of Ca2+ signaling regulation has been intensely investigated. For example, cal-
cineurin can regulate local Ca2+ signaling and contractility in ASM. Meanwhile, the 
Ca2+ influx channel TRPC3 can activate the calcineurin/nuclear factor of activated T 
cells (NFAT) pathway to regulate airway contraction [54].
In addition, ASM can also express some specific receptors such as the transient 
receptor potential ankyrin 1 (TRPA1) or polysaccharides for non-GPCR-mediated 
airway regulation. In particular, TRPA1 and capsaicin receptor 1 (TRPV1) chan-
nels can be activated by PKC resulting in neuromodulation of airway contraction 
[55]. Studies have shown that ASM expresses TRPA1 [56] and TRPV1 [57] as well as 
TRPV4 [58, 59]. TRPA1 has been shown to promote IL-8 secretion in ASM, enhance 
airway inflammation and AHR [60], and mobilize [Ca2+]i [56] while inhibiting the 
proliferation of ASM [61]. In contrast, TRPV1 appears to promote proliferation 
[62]. TRPV4 is associated with an increase in [Ca2+]i [59] and ASM contraction 
and proliferation (Figure 3) [58, 63]. In addition to TRPA, ASM can also express 
epidermal growth factor receptor (EGFR) and hyaluronic acid to participate in 
airway inflammation [64]. The expression of hyaluronic acid is increased during 
inflammation [65] and is involved in the homeostasis of aqueous fluids, cell matrix 
signaling, cell proliferation and migration, and regulation of inflammation [66].
6. ASM cell structure and asthma
Some intracellular and extracellular structures of ASM are closely related to the 
pathological changes of asthma. Caveolae and their regulatory caveolin and cavin 
Figure 3. 
The role of TRP channels in ASM. It was originally published on “Novel drug targets for asthma and COPD: 
Lessons learned from in vitro and in vivo models” of Pulmonary Pharmacology & Therapeutics by Katie 
E. Baker et al.
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proteins are a focus of research. Caveolae have been shown to contain excitatory 
contractile receptors and activate Ca2+ influx channels (including transient receptor 
potential channel (TRPC) subtypes and calcium release-activated calcium channel 
protein 1 (Orai1)) [67, 68]. The decreased expression of its important component, 
caveolin-1, induces an increase in ASM [Ca2+]i and a contractile response and 
promotes ASM proliferation [69]. The relevant mechanisms include a reduction 
in [Ca2+]i influx, increase in sarcoplasmic reticulum Ca
2+ release, and reduction in 
Ca2+ sensitivity through the RhoA pathway. Conversely, pro-inflammatory factors 
such as TNF-α can enhance the expression and function of caveolin-1 [70].
7.  Proliferation and apoptosis of ASM cells and airway remodeling 
during asthma
Airway remodeling is an important pathological change in asthma. The 
increased mass of ASM may be a key feature of airway remodeling, and its hyper-
plasia and hypertrophy are unevenly distributed in bronchi of different sizes. This 
process can enhance airway contraction and airway stenosis, further leading to 
decreased lung function or severe asthma [71]. The underlying causes of ASM 
hypertrophy have been extensively explored. For example, excessive mechanical 
stretching can lead to the release of EGF, which participates in remodeling [72]. In 
addition, Wnt, glycogen synthase kinase 3 beta (GSK3β) [73], or rapamycin target 
protein (mTOR) [74] may also be involved in the regulation of reconfiguration 
caused by mechanical forces. Studies have also shown that hypertrophy is associated 
with increased MLC kinase in ASM [75]. In addition, many signaling pathways have 
been found to be related to ASM proliferation, including p38, p42/p44 MAP kinase 
and PI3/Akt.
During the pathogenesis of asthma, some pro-inflammatory mediators are 
involved in the regulation of ASM proliferation, such as TNF-α, IL-4, IL-5, 
IL-13, TGF-β, thymic stromal lymphopoietin (TSLP), and Th17 family members. 
In addition, some conventional stimuli such as agonists of airway bronchial 
contraction [76] and other locally produced factors [9, 77] may also trigger an 
increase in proliferation under certain circumstances. Recent studies have shown 
that a nonreceptor tyrosine kinase, Abl, promotes ASM mitosis and enhances 
ASM proliferation [78]. It has also been suggested that sex hormones can affect the 
structure and function of the airway because, in some cases, estrogen can reduce 
mitosis and exert antiproliferative effects in the airway [79]. In addition, within 
ASM cells, microRNAs are thought to play an important role in the regulation of 
ASM cell proliferation and migration [80].
Overall, current information indicates that the interaction of multiple signaling 
mechanisms leads to airway remodeling represented by ASM cell proliferation. 
Although many inflammatory pathways can cause cell proliferation, limited data 
exist regarding how to inhibit or block proliferation. Studies have shown that 
regulating the ECM (such as the collagen density) or inducing increased expression 
of caveolin-1 can limit ASM cell proliferation [81] and some therapeutic drugs such 
as corticosteroids and β2 receptor agonists can also reduce proliferation [82]. In 
addition, peroxisome proliferator-activated receptor (PPAR)-γ ligands can attenu-
ate ASM proliferation [83].
In the context of airway remodeling, an increase in ASM mass indicates an 
increase in cell proliferation and reflects a decrease in apoptosis. However, based 
on the current data, the mechanisms of the two are quite different. Th17-associated 
cytokines, IL-18, eotaxin, monocyte inflammatory protein-1a [84], and TRPV1 ago-
nists [85] can alleviate ASM apoptosis. Other studies have found that peroxisome 
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proliferator-activated receptor gamma (PPAR-γ) [86], collagen [87], and vitamin D 
can regulate ASM proliferation without affecting apoptosis.
8. ASM autophagy and asthma
At present, autophagy is considered an adaptive response of cells to survival that 
can promote cell death in the context of disease. This process is essential in main-
taining homeostasis, managing external stress, and regulating cellular capacity. 
Autophagy plays a major role in the immune response to various pathogens, particu-
larly viruses. In the case of asthma, autophagy in the airway epithelium or ASM may 
occur in the context of infection [88]. The current research on the role of autophagy 
in asthma and the types of cells involved is relatively limited. For example, phar-
macological inhibition of gamma-glutamyltransferase 1 (GGT1) has been found to 
induce p53-dependent autophagy in human ASM cells [85]. In addition, excessive 
reactive oxygen species (ROS) that may be present during airway inflammation can 
induce autophagy, thus contributing to the pathophysiology of asthma [89].
9. ASM, miRNA, and asthma
Many studies have examined miRNA-mediated regulation of ASM. During the 
asthma process, many specific miRNAs are thought to play multiple roles in ASM 
[90]. For example, pro-inflammatory cytokines such as IL-1β, TNF-α, and IFNγ can 
downregulate 11 miRNAs, particularly miR-25, miR-140, miR-188, and miR-25. 
In contrast to the above results, another study [80] showed that expression levels 
of miR-146a and miR-146b were elevated in ASM in an IL-1β, TNF-α, and IFNγ-
treated asthma group. Other studies have shown that only miR-146a is an endog-
enous negative regulator of human ASM cells [91].
In terms of airway remodeling, miR-140-3p regulates the important enzyme 
CD38 [92], which may have multiple downstream effects, such as affecting [Ca2+]i 
and proliferation [93–95]. Under the induction of mechanical elongation, miR-26a 
causes ASM hypertrophy by attenuating GSK3β [96]. However, ASM proliferation 
appears to be driven by multiple miRNAs, including miR-10a [97], miR-23b [98], 
miR-138 [99], miR-145 [100], and miR-203 [101]. In general, we have found many 
miRNA pathways in ASM, but many problems remain unresolved, and miRNAs will 
be a focus for targeted asthma therapy in the future.
10. Mitochondria and ASM
Mitochondria in the airway not only produce ATP but are also involved in functions 
such as Ca2+ buffering [102–104], endoplasmic reticulum pathways, Ca2+ influx (such 
as store-operated Ca2+ entry (SOCE)), and cell proliferation and survival. These func-
tions mostly involve fission and fusion of mitochondrial structures, mitochondrial 
biogenesis, mitochondrial autophagy, and ROS destruction [102, 105]. For example, 
consumption of mitochondrial DNA attenuates the concentration of [Ca2+]i in ASM 
[106]. In terms of regulation, TGF-β enhances ASM mitochondrial ROS and promotes 
cytokine secretion [107]. Conversely, airway inflammation impairs mitochondrial Ca2+ 
buffering, resulting in an increase in [Ca2+]i. This damage leads to not only an increase 
in ROS but also an increase in endoplasmic reticulum stress and the unfolded protein 
response (UPR) [108]. These pathways are relevant because they can further influence 
protein expression and function as well as airway remodeling [109, 110].
9© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 




School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional 
Chinese Medicine, Shanghai, China
*Address all correspondence to: vincent.tang@shutcm.edu.cn
11. Conclusions
With the rapid progress in molecular biology, cell biology, and various experi-
mental techniques, research on ASM has developed rapidly, and an increasing 
number of functions have been discovered. When investigating ASM, we should 
consider the presence of surrounding cells and the ECM. Investigation of the role 
of ASM is no longer limited to its contractility, remodeling, and secretion. ASM 
is similar to a “processing station.” It not only is affected by various signals in the 
body to produce biological effects and secrete various signals to act on downstream 
target cells but also feeds back to the upstream pathways or receives feedback 
from downstream pathways to form a complex network. Therefore, a univariant 
study of the mechanism of ASM action is unrealistic. More comprehensive studies 
integrating bioimaging, informatics, and other technologies are needed to conduct 
more accurate target interventions, obtain more precise pathway information, and 
provide new therapeutic targets for asthma.
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